Genetic variability of VEGF pathway genes in six randomized phase III trials assessing the addition of bevacizumab to standard therapy

Sanne de Haas, Paul Delmar, Aruna T. Bansal, Matthieu Moisse, David Miles, Natasha B. Leighl, Bernard Escudier, Eric Van Cutsem, Peter Carmeliet, Stefan Scherer, Céline Pallaud, Diether LambrechtsAngiogenesis 2014 · DOI

BibTeX
@inproceedings{haas2014genetic,
  author = {Sanne de Haas and Paul Delmar and Aruna T. Bansal and Matthieu Moisse and David Miles and Natasha B. Leighl and Bernard Escudier and Eric Van Cutsem and Peter Carmeliet and Stefan Scherer and Céline Pallaud and Diether Lambrechts},
  title = {{Genetic variability of VEGF pathway genes in six randomized phase III trials assessing the addition of bevacizumab to standard therapy}},
  booktitle = {Angiogenesis},
  year = {2014},
  doi = {10.1007/s10456-014-9438-1},
}

Loading related content...

Figure